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Abstract The primary aim of this study was to evaluate
the prevalence of opioid prescriptions in hospitalized
geriatric patients. Other aims were to evaluate factors
associated with opioid prescription, and whether or not
there was consistency between the presence of pain and
prescription. Opioid prescriptions were gathered from the
REgistro POliterapie Societa‘ Italiana di Medicina Interna
(REPOSI) data for the years 2008, 2010 and 2012. 1,380
in-patients, 65? years old, were enrolled in the first reg-
istry run, 1,332 in the second and 1,340 in the third. The
prevalence of opioid prescription was calculated at hospital
admission and discharge. In the third run of the registry, the
degree of pain was assessed by means of a numerical scale.
The prevalence of patients prescribed with opioids at
admission was 3.8 % in the first run, 3.6 % in the second
and 4.1 % in the third, whereas at discharge rates were
slightly higher (5.8, 5.3, and 6.6 %). The most frequently
prescribed agents were mild opioids such as codeine and
tramadol. The number of total prescribed drugs was posi-
tively associated with opioid prescription in the three runs;
in the third, dementia and a better functional status were
inversely associated with opioid prescription. Finally, as
many as 58 % of patients with significant pain at discharge
were prescribed no analgesic at all. The conservative atti-
tude of Italian physicians to prescribe opioids in elderly
patients changed very little between hospital admission and
discharge through a period of 5 years. Reasons for such a
low opioid prescription should be sought in physicians’ and
patients’ concerns and prejudices.
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Introduction
Older adults make up a large portion of the population with
chronic persistent pain, that often interferes with health
status perception, quality of life, cognition and functional
abilities of the elderly [1, 2]. Other recurring consequences
of chronic pain in seniors are depression, anxiety, malnu-
REPOSI denotes the REgistro POliterapie SIMI, Societa` Italiana di
Medicina Interna. The participating units and co-authors are listed in
the Appendix.
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trition and sleep disorders [3, 4]. In comparison with
younger adults, the elderly patient is usually affected by a
higher prevalence of cancer-related and non-cancer-related
pain [5]. Nevertheless, the likelihood of receiving antalgic
medications is negatively related to age [6], so that among
people 85 years old or more, one of three receives no
treatment for pain control, and in only 10 % of them is an
opioid prescribed [6].
Opioids are the most powerful painkillers. Their use is
appropriate for the treatment of moderate-to-severe chronic
pain (5–10 point pain intensity) with the goal to control this
symptom and to improve functions and quality of life [7].
The main challenges of opioid prescription in the elderly
are to choose the most appropriate molecule in relation to
the patients’ clinical conditions, to find the minimum
effective dose able to relieve pain, but also to monitor and
manage any drug-related adverse events. On the other
hand, pain alleviation is even more challenging in the
elderly if compounds other than opioids are used, such as
non-steroidal anti-inflammatory drugs, owing to their
unfavorable side effect profile, mainly the onset of renal
failure and thrombosis risk. Indeed, the American Geriat-
rics Society suggests avoiding the use of these drugs, and
prefers opioids in old patients with moderate-to-severe
chronic pain [8]. Italy is one of the European countries with
the lowest per capita opioid expenditure, [9] but ranks first
in Europe for the prescription of non-steroidal anti-
inflammatory drugs [10].
With this background, our primary goal was to evaluate
the prevalence and type of analgesic and opioid prescrip-
tions at hospital admission and discharge in elderly patients
through the use of data from three runs (2008, 2010, 2012)
of the REgistro POliterapie Societa‘ Italiana di Medicina
Interna (REPOSI) registry. Additional aims were the
evaluation of factors associated with opioid prescription,
and the relationship between presence of pain and anal-
gesic prescription at hospital discharge.
Methods
Data collection
The REPOSI registry is a collaborative and independent
joint effort of the Italian Society of Internal Medicine
(SIMI, Societa` Italiana di Medicina Interna), the Mario
Negri Institute of Pharmacological Research and the IR-
CCS Ca’ Granda Maggiore Policlinico Hospital Founda-
tion. The design of REPOSI was previously described
[11]. Briefly, this registry was designed to create a net-
work of internal medicine and geriatric wards to evaluate
several features of elderly patients affected by multiple
diseases and prescribed with multiple medications. The
main aims of REPOSI were to describe prevalence of
concurrent diseases and multiple treatments in the hos-
pitalized elderly, to correlate clinical characteristics of
these patients with type and number of diseases and
treatments, to evaluate the main clinical outcomes at
hospital discharge and compare drug prescription at
admission, discharge and follow-up.
All the patients consecutively recruited were 65 years
old or older. Participation was voluntary and an informed
consent was signed. The registry enrolled patients con-
secutively admitted to the participating hospital wards (36
in 2008, 66 in 2010 and 70 in 2012) during a period of
4 weeks, 3 months apart from each other (in February,
June, September and December 2008, 2010, and 2012). A
standardized web-based case report form was filled-in by
the attending physicians, including socio-demographic
factors, clinical parameters, diagnoses and medications
prescribed at hospital admission and discharge, plus clini-
cal events occurring during hospitalization. Each wave of
the REPOSI was slightly different according to the mini-
mum data set. This was decided to improve the quality and
increase the quantity of the data. In particular, during the
first wave in 2008, data on functional and cognitive status
were not collected. All the data collected and recorded
were checked by a central monitoring institution (the Mario
Negri Institute for Pharmacological Research, Milan) for
consistency and accuracy (with contacts of the peripheral
clinical centers if needed).
The study was approved by the ethics committee of the
IRCCS Ca’ Granda Maggiore Policlinico Hospital Foun-
dation, Milan.
Assessment of drug prescriptions
All the drugs taken at the time of hospital admission, and
those prescribed at discharge were recorded and encoded
according to the Anatomical Therapeutic Chemical (ATC)
classification system [12]. In each run of the registry, the
physicians filling medication prescriptions were required to
report the indication for each prescription (e.g., ‘trama-
dol’=’treatment of pain in metastatic cancer’; or ‘citalo-
pram’=’treatment of depression’, etc.). Prevalence of
opioids prescribed at admission was calculated on the total
number of patients, whereas patients who died or were
transferred to another hospital ward during hospitalization
were excluded from prevalence calculation at hospital
discharge. Polypharmacy was described as the concomitant
prescription of five or more drugs [13].
Assessment of disease diagnosis
Diseases examined in this study were collected at hospital
discharge on the basis of clinical examination, medical
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history and laboratory and instrumental data. The Interna-
tional Classification of Diseases, Ninth Revision (ICD-9)
was used to classify the diseases [14].
Assessment of pain intensity
Pain intensity was specifically assessed only in the third
run of the registry (2012), because collection of this
information was not foreseen in the data set for the first two
runs (2008, 2010). Pain intensity was measured by means
of 0 (no pain) to 10 point (the worst pain one can imagine)
numeric rating scale (NRS). This measure was obtained
both at the time of hospital admission and at discharge.
Assessment of cognitive and functional status
The data on the cognitive and functional status were
obtained only in the second and third runs of the registry.
The short blessed test (SBT) was performed within 2 days
of hospital admission. SBT is a 6-item orientation–mem-
ory–concentration test validated as a measure of cognitive
impairment [15]. The final score varies from 0 to 28; an
increasing score indicates worse cognitive status. The
Barthel Index, used to assess performance in basic activities
of daily living [16], considers 10 basic functions and yields
a score of 0–100, a higher score being associated with a
greater likelihood of being able to live at home with a good
degree of independence following hospital discharge.
Statistical analysis
Socio-demographic and clinical characteristics of the case
material, as well as the prevalence of opioid prescription
for analgesia were described using univariate analysis
(mean or percentage). Logistic regression models were
employed to evaluate factors associated with opioid pre-
scription at hospital discharge in the three REPOSI runs.
Independent variables were age (years), gender and total
number of drugs prescribed in the three runs, plus diagnosis
of dementia, severe constipation and functional status as
measured with the Barthel Index in the last two runs. All
the statistical calculations were performed with the soft-
ware STATA 12th version (College Station, Texas, US).
Results
1,332 patients aged more than 65 years were enrolled in the
2008, 1,380 in 2010 and 1,340 in 2012. Socio-demographic
characteristics of the three samples were similar (Table 1);
the mean age was 79.3 years (SD = 7.5) in the first, 78.9
(SD = 7.3) in the second and 79.3 (SD = 7.4) in the third.
Males and females were almost equally distributed. The
Table 1 Characteristics of the three REPOSI samples (2008, 2010,
2012)
Sample
2008
(N = 1,332)
Sample
2010
(N = 1,380)
Sample
2012
(N = 1,340)
Age, years, mean (SD) 79.3 (7.5) 78.9 (7.3) 79.3 (7.4)
65–74 years 356 (26.7) 387 (28.0) 351 (26.4)
75–84 years 606 (45.5) 644 (46.7) 583 (43.8)
C85 years 370 (27.8) 349 (25.3) 396 (29.8)
Male, number (%) 610 (45.8) 681 (49.3) 657 (49.1)
Education, years, mean
(SD)
6.3 (3.7) 7.1 (4.0) 6.4 (4.3)
Length of hospital stay,
days, median (range)
9 (6–14) 9 (6–14) 9 (6–14)
Total drugs at
admission, mean (SD)
4.9 (2.8) 5.3 (2.8) 5.4 (3.2)
Total drugs at
discharge, mean (SD)
6.0 (2.9) 6.3 (2.8) 6.4 (3.1)
Opioids at admission,
number (%)
50 (3.8) 49 (3.6) 55 (4.1)
Opioids at discharge,
number (%)
67 (5.8) 63 (5.3) 77 (6.6)
Short blessed test, mean
(SD)
– 9.9 (8.1) 9.1 (7.8)
Barthel index, mean
(SD)
– 76.8 (30.7) 72.6 (32.5)
Dementia diagnosis,
number (%)
122 (9.2) 90 (6.5) 116 (8.7)
Severe constipation,
number (%)
34 (2.6) 20 (1.4) 9 (0.7)
Discharged, number
(%)
1,155 (86.7) 1,178 (87.4) 1,166 (88.6)
Transferred to another
hospital ward, number
(%)
111 (8.3) 120 (8.9) 108 (8.2)
In-hospital mortality,
number (%)
66 (5.0) 50 (3.6) 42 (3.1)
Ten missing values for age in wave 3
Table 2 Prevalence (%) of diseases potentially painful in the three
samples of REPOSI
Diseases Sample
2008
Sample
2010
Sample
2012
Diabetes mellitus 27.0 27.2 29.8
Cerebrovascular disease 26.5 21.6 21.7
Coronary heart disease 25.5 24.1 20.2
Chronic obstructive pulmonary
disease
21.7 25.2 24.5
Malignancy 19.7 17.3 15.2
Heart failure 18.6 19.1 16.6
Gastric diseases 17.1 24.9 20.6
Gut diseases 11.1 13.9 13.9
Arthritis 7.5 9.9 11.7
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mean number of prescribed drugs was also similar in the
three samples, both at hospital admission and discharge.
Median length of hospital stay was the same (9 days, with a
range of 6–14). No statistically significant differences were
found according to the prevalence of potentially painful
diseases in the three registry runs (Table 2). The proportion
of patients discharged from hospital was 86.7, 87.4 and
88.6 %, respectively. In-hospital mortality changed from
5.0 % in the first run to 3.1 % in the third (p value for
trend = 0.05).
The proportion of patients prescribed with analgesic
opioids at hospital admission was 3.8 % in 2008 the first
run, 3.6 % in the second and 4.1 % in the third, whereas at
hospital discharge the prescription rates were slightly
higher (5.8, 5.3 and 6.6 %). The most frequently prescribed
opioids were weak opioids such as codeine and tramadol
(Table 3). Pertaining to the indications for their prescrip-
tion, in the 2008 registry run 26 % of patients received
these drugs for cancer pain, 48 % for non-cancer pain (e.g.,
osteoarthritis), whereas in 26 % the indication was not
reported. In 2010, 14 % of the patients received opioids for
cancer pain, 60 % for non-cancer pain, in 26 % the
indication was not reported. In 2012, 20 % of patients
received opioids for cancer pain, 45 % for non-cancer pain
and in 35 % prescription indication was missing.
Univariate analysis and logistic regression models were
run to identify factors associated with opioid prescription
(Table 4). In all the three registry runs, age and gender
were not associated with prescription. The total number of
all prescribed drugs at discharge (after excluding opioids)
was the only factor independently associated with opioid
prescription, similarly in the three runs (OR = 1.1; 95 %
CI = 1.0–1.2 in 2008; OR = 1.15; 95 % CI = 1.10–1.24
in 2010; OR = 1.13; 95 % CI = 1.10–1.2 in 2012). In the
third run, a diagnosis of dementia and a better functional
status were inversely related with opioid prescription (data
not shown).
Presence of pain at hospital discharge, specifically
evaluated only in the 2012 run, indicated that among 1,166
patients 121 (10.4 %) were discharged with pain, 22 of
them with cancer pain. Pain intensity measures varied from
1 to 10, with a mean value of 4.0 (SD = 2.1). Only 37
(30.5 %) of patients with pain were prescribed opioids at
the time of discharge. Pain intensity measures were
Table 3 Prescriptions of
opioids during the three samples
of REPOSI (2008, 2010, 2012)
at hospital admission and
discharge
Sample 2008 Sample 2010 Sample 2012
Admission
(N = 1,332)
Discharge
(N = 1,155)
Admission
(N = 1,380)
Discharge
(N = 1,178)
Admission
(N = 1,340)
Discharge
(N = 1,166)
Codeine 9 18 15 13 7 30
Tramadol 18 30 15 25 17 17
Morphine 5 11 4 0 6 10
Hydromorphone 0 0 3 3 3 1
Oxycodone 4 3 4 8 12 12
Fentanyl 13 12 9 8 9 10
Buprenorphine 2 6 2 4 2 2
Tapentadol 0 0 0 0 3 4
Table 4 Univariate associations with opioid prescription at hospital discharge in the three samples of REPOSI
Sample 2008 Sample 2010 Sample 2012
Opioids Opioids Opioids
No Yes No Yes No Yes
Age, yrs, mean (SD) 79.2 (7.5) 77.7 (8.0) 78.9 (7.4) 78.6 (7.9) 79.3 (7.5) 78.7 (6.9)
Male, number (%) 506 (46.5) 29 (43.3) 540 (48.4) 25 (39.7) 523 (48.1) 40 (51.9)
Total drugs at discharge, mean (SD) 5.9 (2.8) 6.4 (3.3) 6.2 (2.8) 6.9 (3.0)* 6.3 (3.1) 7.1 (2.8)
SBT, mean (SD) – – 9.6 (8.0) 8.4 (8.8) 9.1 (7.8) 8.6 (7.1)
Barthel Index, mean (SD) – – 78.4 (29.6) 72.9 (31.6) 74.9 (31.1) 68.1 (32.8)
Dementia diagnosis, number (%) 102 (9.4) 4 (6.0) 84 (7.5) 6 (9.5) 113 (10.4) 3 (3.9)
Severe constipation, number (%) 23 (2.1) 3 (4.5) 19 (1.7) 1 (1.6) 7 (0.6) 2 (2.6)*
* p = 0.05
 p \ 0.01
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available for all these 37 patients: 16 of them (43.2 %) had
a score C4. Amongst the remaining 84, 12 were prescribed
with acetaminophen and two with non-steroidal anti-
inflammatory drugs. Thus, 70 of patients with pain
(57.8 %) were discharged with no analgesic prescription.
Pain intensity was available for 58 of them and 29 (50 %)
had a value C4 (Table 5).
Discussion
It is well established that the prevalence of chronic pain
climbs steadily until the seventh decade of life [17], often
exceeding 50 % in community-based cohorts of people and
up to 80 % in the frame of residential care [18, 19]. In a
recent study [20] evaluating cancer pain in 24, 410 patients
older than 65 years, 63 % had pain: 20 % mild, 20 %
moderate and 23 % severe. In this Canadian study 24 %
patients with mild, 45 % with moderate and 67 % with
severe pain received opioids [20]. These literature data,
that establish the impact of pain in the elderly and make us
aware of the need to provide adequate pain relief with
opioids, are in striking contrast with our registry findings:
in all the three REPOSI runs (spanning a time interval of
5 years), the prevalence of opioid prescription at hospital
admission ranged from as little as 3.6 to 4.1 % and
increased marginally at discharge from 5.3 to 6.6 %. The
most frequently prescribed agents were weak opioids, such
as codeine and tramadol. The only factor associated with
opioid prescription in all the REPOSI runs was the total
number of prescribed drugs. In the third run, a diagnosis of
dementia and a better functional status of the patients were
inversely correlated with opioids prescription. Finally, at
least half of the patients with significant pain at discharge
were not prescribed any analgesic.
Data from the Italian Observatory on Medications
(OsMed) showed a 17 % average increase in the pre-
scription of opioids and adjuvant analgesics for neuro-
pathic pain from 2004 to 2012, ranging in prevalence from
7.6 to 23.5 % in the general population, albeit with large
variations in different regions. In the same time period,
major and minor opioid prescription did increase by 12.1
and 46.3 %, respectively [21]. The present data from
REPOSI show a much smaller increase of opioid pre-
scription from 2008 to 2012 to hospitalized elderly
patients, who were very similar in the three registry runs
pertaining to socio-demographic characteristics, age, gen-
der, health status, diseases potentially painful and total
number of prescribed drugs. Furthermore, the observed tiny
increase of opioid prescription between hospital admission
and discharge indicates that there were similarly conser-
vative prescription attitudes among general practitioners
(who are usually the prescribers before hospital admission)
and internists and geriatricians (who are the final pre-
scribers at the time of hospital discharge). The small
prevalence of opioid prescription in this REPOSI sample
compared to the general Italian population, the higher
prescription rate of weak than strong opioids, as well as the
fact that more than 50 % of patients with pain at the time of
discharge were not prescribed any analgesic are in line with
previous reports on pain undertreatment of the elderly in
Italy [6].
In order to facilitate opioid prescription, a ministerial
bill permitted, in June 2009, the prescription of these drugs
on the basis of a simple no-repeat prescription, using the
usual pad of the Italian Health Service. Hence, the first
REPOSI run in 2008 took place before the enforcement of
this bill, but the next two runs (2010, 2012) took place after
the bill. Yet, there was no evidence that this easing bill has
changed the pattern of spare prescription of opioids.
There are several possible explanations for this pre-
scription behavior. One is knowledge that opioids may
cause a variety of adverse effects that can be particularly
problematic in the frail elderly. Whereas physicians
working in specialized hospital wards (such as oncology,
pain therapy and palliative care, anesthesiology and sur-
gery units) are more user-friendly with opioids, internal
medicine and geriatric physicians, as well as general
practitioners, may not fully appreciate that understanding,
anticipating and managing the side effects of opioids is an
important component of their active strategy towards pain
management in the elderly [22]. For instance, an accurate
personalized modulation of the daily dose may limit
adverse reactions. Furthermore, according to the STOPP
criteria for prescription appropriateness in the elderly,
opioids should be avoided for long-term use in people with
dementia unless in severe pain, as well as in those at high
risk of falls [23]. Indeed, a diagnosis of dementia and a
better functional status were inversely associated with
opioid prescription in the last REPOSI run. Finally, older
patients themselves may not agree with opioid prescription
because of multiple concerns and prejudices (e.g., fear of
addiction, constipation, negative social stigma), which may
limit their compliance with this prescribed therapy. Con-
sistently with the reasons explained above, a preferential
Table 5 Allocation of the 121 painful patients according to analgesic
prescription at hospital discharge
Patients
(N, %)
Subjects with
pain intensity C4
Analgesic
prescription
37 (30.5) 16 Opioids
12 (9.9) 5 Acetaminophen
2 (1.7) 0 NSAIDs
70 (57.9) 29 None
NSAIDS denotes non-steroidal anti-inflammatory drug
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choice of weak opioids, such as codeine and tramadol, was
indeed observed in this study.
Strengths and limitations
A strength of the REPOSI registry is the multicenter pro-
spective observational design that involves internal medi-
cine and geriatric wards throughout Italy, resulting in a
sample representative of the hospitalized elderly popula-
tion in the country; and the inclusion of patients during a
period of four different weeks, in order to balance the
effect of seasons on acute diseases leading to hospitaliza-
tion. However, limitations need to be mentioned. Hospital
admissions are sometime selective on the basis of ward
characteristics, severity of disease, associated medical
conditions and admissions policies that may vary from
hospital to hospital. Moreover, the assessment of pain
intensity was included only in third run of REPOSI, so that
this information was obtained only partially.
Conclusions
Opioid prescription did not change over a 5-year period in
hospitalized elderly patients in Italy. The Ministry of
Health decree, focused on reducing the complexity of
prescription, had little influence on the therapeutic deci-
sions of hospital internists. Furthermore, a high degree of
inconsistency was found between presence of pain and
analgesic prescription at hospital discharge. Reasons for
the persistence of a low opioid prescription and pain under
treatment in elderly patients should be sought in physi-
cians’ and patients’ prejudices and concerns that warrant
more information and education.
Conflict of interest None.
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